FDA Adverse Event Malfunction Summary report: N

ARCHITECT HBSAG

MDR report key: 25287982 · Received May 26, 2026

Report

Report Number
3008344661-2026-00077
Event Type
Malfunction
Date Received
May 26, 2026
Date of Event
May 15, 2026
Report Date
May 26, 2026
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
LOM
UDI-DI
00380740167721
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SECTION A PATIENT INFORMATION: REFER TO SECTION B5 FOR COMPLETE PATIENT INFORMATION. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, ARCHITECT HBSAG, LIST NUMBER 06C36 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, ARCHITECT HBSAG QUALITATIVE, LIST NUMBER 04P53, WITH 510K/PMA/BLA NUMBER P110029.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSE NONREACTIVE ARCHITECT HBSAG ON A 40-YEAR-OLD MALE PATIENT WHO WAS DIAGNOSED WITH HEPATITIS B. THE RESULTS PROVIDED WERE: (B)(6) 2026, SID (B)(6); RESULT WAS = 0.01 IU/ML (NONREACTIVE), REPEAT RESULT FROM SIEMENS= NONREACTIVE (NO DATA PROVIDED), HBVDNA RESULT = 2.29 (POSITIVE). HISTORICAL RESULTS FROM (B)(6) 2026; 2.55 IU/ML (REACTIVE) & SIEMENS RESULTS WERE ALSO REACTIVE. (NO DATA PROVIDED). HBVDNA = 2.12 IU/ML (POSITIVE ON (B)(6) 2026). HBSAG = (REFERENCE RANGE: < 0.05 IU/ML IS NONREACTIVE, = 0.05 IU/ML IS REACTIVE). HBV-DNA= (REFERENCE RANGE: <20 IU/ML). OTHER RESULTS = ON (B)(6) 2026; ALT, AST, TBIL, AND DBIL RESULTS WERE ALL HIGHER THAN THE REFERENCE RANGE AND RESULTS DECLINED AFTER RECEIVING TREATMENT TO PROTECT THE LIVER, LOWER ENZYMES, AND REDUCE JAUNDICE. CUSTOMER ONLY QUESTION HBSAG RESULTS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
179175 ARCHITECT HBSAG TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) LOM ABBOTT IRELAND DIAGNOSTICS DIVISION 82117FZ01 00380740167721

Patients

Seq Age Sex Outcome Treatment
1